+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Carboxes 36761-83-8
36761-83-8,MFCD01710217
Catalog No.:AA00C9Z9

36761-83-8 | dechloroethylcyclophosphamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
3 weeks  
$426.00   $298.00
- +
10mg
3 weeks  
$499.00   $349.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00C9Z9
Chemical Name:
dechloroethylcyclophosphamide
CAS Number:
36761-83-8
Molecular Formula:
C5H12ClN2O2P
Molecular Weight:
198.5877
MDL Number:
MFCD01710217
SMILES:
ClCCNP1(=O)NCCCO1
Properties
Computed Properties
 
Complexity:
167  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
1  
XLogP3:
-0.3  

Literature

Title: Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapy.

Journal: European journal of cancer (Oxford, England : 1990) 20110701

Title: Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MS.

Journal: Chirality 20090701

Title: Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.

Journal: Clinical pharmacokinetics 20070101

Title: Role of GSTM1, GSTP1, and GSTT1 gene polymorphism in ifosfamide metabolism affecting neurotoxicity and nephrotoxicity in children.

Journal: Journal of pediatric hematology/oncology 20051101

Title: Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity.

Journal: Pediatric nephrology (Berlin, Germany) 20050701

Title: Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcoma.

Journal: European journal of clinical pharmacology 20010901

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 36761-83-8
173547-45-0

173547-45-0

 3778-73-2

3778-73-2

 22089-22-1

22089-22-1

 6055-19-2

6055-19-2

 1189701-13-0

1189701-13-0

 50-18-0

50-18-0
Building Blocks
More >
Tags:36761-83-8 Molecular Formula|36761-83-8 MDL|36761-83-8 SMILES|36761-83-8 dechloroethylcyclophosphamide